Can a New AI Tool Improve Detection of Incidental Pulmonary Embolism on CT?
Noting that only 25 percent of incidental emboli are identified in reporting of initial computed tomography (CT) exams, Avicenna.AI said the artificial intelligence (AI)-enabled CINA-iPE is geared toward detecting incidental pulmonary embolism (PE) on chest CT scans.
Avicenna.AI has launched CINA-iPE, an artificial intelligence (AI)-powered modality, which may facilitate the diagnosis of incidental pulmonary embolism (PE) on chest computed tomography (CT) examinations.
The company noted that CINA-iPE, which utilizes AI to analyze chest CT scans for incidental PE, is the first modality for CINA Incidental, a new suite of imaging tools geared toward enhancing CT diagnosis of unsuspected pathologies.
While incidental PE is frequently detected on chest CT, Avicenna.AI emphasized that incidental PE is a significant cause of mortality among patients with cancer and maintained that incidental emboli are commonly missed in reporting for initial CT assessments.
“Pulmonary embolism is a dangerous, life-threatening condition and with CINA-iPE, we hope to increase the number of patients identified with incidental PE and help improve their outcomes,” noted Cyril Di Grandi, cofounder and chief executive officer of Avicenna.AI.
Avicenna.AI said it will debut CINA-iPE at the European Congress of Radiology March 1-5, 2023 in Vienna, Austria.
(Editor’s note: For related content, see “Viz.ai Launches AI-Powered Vascular Imaging Software” and “PE Triage Platform from RapidAI Receives FDA 510(k) Clearance.”)
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
